The North America neurovascular devices market is witnessing steady growth due to advanced healthcare infrastructure, increasing adoption of minimally invasive neurointerventional procedures, and greater availability of specialized stroke centers. Rising demand for thrombectomy, aneurysm coiling, embolization, and other endovascular technologies is encouraging continued innovation in neurovascular devices. Strong clinical research activity and supportive reimbursement environments are also helping expand access to advanced neurovascular treatments across the region.

The neurovascular devices market size in 2021 stood at US$ 3.22 billion and is projected to reach US$ 5.79 billion by 2031. The market is expected to register a CAGR of 6.2% in 2023–2031.

Rising Prevalence of Neurological Disorders Supports Market Growth

The increasing prevalence of neurological diseases is one of the major factors supporting demand for neurovascular devices. Stroke and cerebral aneurysms require timely diagnosis and intervention, creating a sustained need for specialized devices capable of restoring blood flow or managing abnormal blood vessels. Aging populations and changing lifestyle patterns are also contributing to the incidence of neurological disorders.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPHE100000781

The growing emphasis on early diagnosis and treatment is encouraging healthcare providers to invest in advanced neurovascular technologies. Government initiatives aimed at increasing awareness of neurological diseases and improving access to treatment are further supporting demand. The combination of rising disease burden and improvements in neurovascular intervention techniques is expected to strengthen market development.

Shift Toward Minimally Invasive Neurovascular Procedures

The growing preference for minimally invasive procedures is a key trend shaping the industry. Compared with conventional open surgical approaches, minimally invasive neurovascular interventions can reduce procedural invasiveness and support shorter recovery periods. Improvements in imaging technologies have also enabled physicians to perform complex procedures with greater precision.

Advanced devices such as neurothrombectomy systems, embolization devices, stents, and support devices are increasingly important in modern neurointerventional procedures. Ongoing research and greater awareness among neurosurgeons regarding minimally invasive treatment options are creating additional opportunities for manufacturers.

Product Innovation and Technological Development

Technological innovation remains an important factor influencing the neurovascular devices market. Companies are developing sophisticated devices designed to improve the safety, efficiency, and precision of procedures involving delicate cerebral blood vessels. The development of innovative aneurysm treatment technologies is particularly significant as physicians seek improved approaches for managing complex cases.

Based on product, the market is segmented into neurothrombectomy devices, aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, and support devices. Aneurysm coiling and embolization devices held the largest market share in 2023 and are expected to register the highest CAGR during the forecast period. This segment includes embolic coils, bare detachable coils, coated detachable coils, flow diversion devices, and liquid embolic agents.

Ischemic Stroke Represents a Major Application Area

By application, the neurovascular devices market is categorized into cerebral aneurysms, ischemic strokes, arteriovenous malformations and fistulas, and other applications. Ischemic strokes represented the largest application segment in 2023 and are expected to register the highest CAGR during the forecast period.

The growing need for rapid intervention in stroke cases is increasing the importance of devices that can facilitate clot removal and restore blood flow. Neurothrombectomy technologies are particularly relevant in this area, as they enable endovascular removal of clots associated with ischemic stroke. Continued clinical research and improvements in device design may further expand the use of these technologies.

Hospitals Remain Key End Users

Hospitals represent a significant end-user segment because of their advanced healthcare infrastructure, availability of specialized professionals, and capacity to perform complex neurovascular procedures. The market is segmented by end user into hospitals, ambulatory surgical centers, and specialized clinics. Hospitals held the largest share in 2023 and are expected to register the highest CAGR during the forecast period. Favorable reimbursement policies and access to advanced healthcare facilities are among the factors supporting this segment.

North America Leads the Market

North America dominated the neurovascular devices market, supported by the increasing prevalence of neurological diseases, higher diagnosis and treatment rates, healthcare spending, and reimbursement support. The US represents a key market due to increasing incidences of neurovascular diseases, rising demand for minimally invasive procedures, and a significantly growing aging population.

Technological advancements, research and development activities, product approvals, partnerships, acquisitions, and the presence of established medical device companies further contribute to regional growth. Meanwhile, Asia Pacific is anticipated to record the highest CAGR in the coming years, creating opportunities for companies seeking geographic expansion.

Competitive Landscape and Key Players

The competitive environment is characterized by product innovation, portfolio expansion, regulatory approvals, strategic partnerships, acquisitions, and investments in research and development. Key companies identified in the market include:

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson Services, Inc.
• Acandis GmbH & Co. KG
• MicroPort Scientific Corporation
• Terumo Corporation
• Penumbra, Inc.
• phenox GmbH
• Integer Holdings Corporation
• Memry Corporation

Recent industry developments demonstrate the focus on strengthening neurovascular portfolios. For example, Stryker completed the acquisition of Cerus Endovascular, adding products for intracranial aneurysm treatment to its neurovascular portfolio. Stryker also launched a neurovascular research and development laboratory in Asia Pacific to support innovation in stroke care.

Future Outlook

The future of the neurovascular devices market will be shaped by continued technological innovation, increasing adoption of minimally invasive procedures, and the growing burden of neurological diseases. Product developers are expected to focus on devices that improve procedural precision, safety, and treatment effectiveness.

Opportunities are also likely to emerge from expanding healthcare infrastructure and growing demand in developing markets. Asia Pacific is particularly positioned for strong growth, while North America is expected to remain an important market because of advanced healthcare capabilities, reimbursement support, and ongoing innovation. Increasing clinical research, product approvals, strategic collaborations, and development of next-generation neurovascular technologies are expected to support the market's continued expansion through the forecast period.

Related Reports @

Stroke Management Market Analysis, Size, and Share by 2031

Thrombectomy Devices Market Analysis, Size, and Share by 2031

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish